The role of heparan sulfate as determining pathogenic factor in complement factor H-associated diseases
- 1 February 2015
- journal article
- review article
- Published by Elsevier in Molecular Immunology
- Vol. 63 (2) , 203-208
Abstract
No abstract availableKeywords
Funding Information
- Radboudumc PhD Fellowship grant program
- Dutch Kidney Foundation
- GLYCOREN
This publication has 60 references indexed in Scilit:
- Recent insights into C3 glomerulopathyNephrology Dialysis Transplantation, 2013
- Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapyPediatric Nephrology, 2011
- Zinc Binding to the Tyr402 and His402 Allotypes of Complement Factor H: Possible Implications for Age-Related Macular DegenerationJournal of Molecular Biology, 2011
- Structural basis for engagement by complement factor H of C3b on a self surfaceNature Structural & Molecular Biology, 2011
- Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesisOncogene, 2009
- Rapid Purification and High Sensitivity Analysis of Heparan Sulfate from Cells and TissuesJournal of Biological Chemistry, 2009
- Mutations of Factor H Impair Regulation of Surface-bound C3b by Three Mechanisms in Atypical Hemolytic Uremic SyndromeJournal of Biological Chemistry, 2009
- Translational Mini-Review Series on Complement Factor H: Structural and functional correlations for factor HClinical and Experimental Immunology, 2007
- Translational Mini-Review Series on Complement Factor H: Genetics and disease associations of human complement factor HClinical and Experimental Immunology, 2007
- Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic SyndromePLOS Genetics, 2007